-
1
Prevalence of Dual-Positivity for Both Hepatitis B e Antigen and Hepatitis B e Antibody Among Hospitalized Patients with Chronic Hepatitis B Virus Infection
Published 2021-09-01Subjects: “…hepatitis b e antigen…”
Get full text
Article -
2
Nucleos(t)ide Analogue Treatment Cessation in Hepatitis B e Antigen-negative Chronic Hepatitis B Patients: A Retrospective Single-center Study
Published 2020-12-01Subjects: Get full text
Article -
3
Nomogram for evaluating obvious liver inflammation in treatment-naïve HBeAg positive chronic hepatitis B virus infection patients with normal ALT
Published 2023-12-01Subjects: Get full text
Article -
4
Prevalence of hepatitis B e antigenemia in Bahraini hepatitis B patients: A retrospective, single‐center study
Published 2021-03-01Subjects: Get full text
Article -
5
Dynamic Characteristics of Serum Hepatitis B Surface Antigen in Chinese Chronic Hepatitis B Patients Receiving 7 Years of Entecavir Therapy
Published 2016-01-01Subjects: “…Chronic Hepatitis B; Entecavir; Hepatitis B e Antigen; Hepatitis B Surface Antigen…”
Get full text
Article -
6
-
7
Hepatitis B e Antigen Induces NKG2A+ Natural Killer Cell Dysfunction via Regulatory T Cell-Derived Interleukin 10 in Chronic Hepatitis B Virus Infection
Published 2020-06-01Subjects: “…hepatitis B e antigen…”
Get full text
Article -
8
Dynamic changes of cytokine profiles and virological markers during 48 weeks of entecavir treatment for HBeAg-positive chronic hepatitis B
Published 2022-09-01Subjects: Get full text
Article -
9
A nomogram based on HBeAg, AST, and age to predict non-minimal liver inflammation in CHB patients with ALT <80 U/L
Published 2023-01-01Subjects: Get full text
Article -
10
Baseline hepatitis B surface antigen quantitation can predict virologic response in entecavir-treated chronic hepatitis B patients
Published 2014-11-01Subjects: Get full text
Article -
11
-
12
Host genetic factors in predicting response status in chronic hepatitis B patients discontinuing nucleos(t)ide analogs
Published 2018-01-01Subjects: Get full text
Article -
13
-
14
HBV-DNA level at 6 months of entecavir treatment predicts HBeAg loss in HBeAg-positive chronic hepatitis B patients
Published 2015-04-01Subjects: Get full text
Article -
15
-
16
The risk of perinatal hepatitis B virus transmission: hepatitis B e antigen (HBeAg) prevalence estimates for all world regions
Published 2012-06-01Subjects: Get full text
Article -
17
Hepatitis B Core Antigen Expression in Hepatocytes Reflects Viral Response to Entecavir in Chronic Hepatitis B Patients
Published 2013-07-01Subjects: Get full text
Article -
18
Negative Correlation of Serum Hepatitis B Surface Antigen and Hepatitis B e Antigen Levels with the Severity of Liver Inflammation in Treatment-naïve Patients with Chronic Hepatiti...
Published 2017-01-01Subjects: “…Chronic Hepatitis B Virus Infection; Hepatitis B e Antigen; Hepatitis B Surface Antigen; Liver Inflammation…”
Get full text
Article -
19
Dynamics of Serum Pregenome RNA in Chronic Hepatitis B Patients Receiving 96-Month Nucleos(t)ide Analog Therapy
Published 2022-02-01Subjects: Get full text
Article -
20
Validation of quantitative hepatitis B virus DNA and hepatitis B e antigen titers in patients of chronic hepatitis B virus infection on entecavir therapy at tertiary care hospital
Published 2025-01-01Subjects: “…hepatitis b surface antigen; chronic hepatitis; hepatitis b virus dna; entecavir; hepatitis b e antigen…”
Get full text
Article